Zars Files For IPO

Pharmaceutical company ZARS Inc. announced Monday that it intends to go public in an IPO on the Nasdaq. The firm filed a registration statement with the U.S. Securities and Exchange Commission Friday, saying that it will raise up to $86.25M in its IPO. The number and price of its common stock shares has not yet been determined. Cowen and Company and CIBC World Markets are book-running managers for the offering, and Leerink Swann & Co. and Susquehanna Financial Group are serving as co-managers. Based in Salt Lake City, Utah, ZARS specializes in the development and commercialization of topically applied drugs. The firm is backed by Draper Fisher Jurvetson, Wasatch Ventures, and vSpring Capital.


More Headlines